Cargando…
Prognostic Impact of DHRS9 Overexpression in Pancreatic Cancer
PURPOSE: Pancreatic cancer (PC) has poor prognosis despite systemic treatment. Dehydrogenase/reductase member 9 (DHRS9) has been reported to be involved in many events of tumorigenesis, but its prognostic impact in PC remains undetermined. Thus, this study aimed to explore the association between DH...
Autores principales: | Li, Huang-bao, Zhou, Jun, Zhao, Fengqing, Yu, Jiayin, Xu, Longsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381829/ https://www.ncbi.nlm.nih.gov/pubmed/32765099 http://dx.doi.org/10.2147/CMAR.S251897 |
Ejemplares similares
-
Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance
por: Hu, Liang, et al.
Publicado: (2015) -
DHRS7 is an immune-related prognostic biomarker of KIRC and pan-cancer
por: Tang, Sheng, et al.
Publicado: (2022) -
DHRS9 Is a Stable Marker of Human Regulatory Macrophages
por: Riquelme, Paloma, et al.
Publicado: (2017) -
Are Mutations in the DHRS9 Gene Causally Linked to Epilepsy? A Case Report
por: Calì, Francesco, et al.
Publicado: (2020) -
CircDHRS3 inhibits prostate cancer cell proliferation and metastasis through the circDHRS3/miR-421/MEIS2 axis
por: Dai, Xiyu, et al.
Publicado: (2023)